| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | — | +571.4% |
| Cost of Revenue | $646K | — | +404.7% |
| Gross Profit | $811K | — | +811.2% |
| R&D Expense | $375K | — | -51.9% |
| SG&A Expense | $3.3M | — | +67.1% |
| Operating Income | -$2.8M | — | -7.2% |
| Pre-tax Income | -$3.3M | — | -25.3% |
| Income Tax | $0 | — | — |
| Net Income | -$3.3M | — | -25.3% |
| EPS (Basic) | -$0.08 | — | +0.0% |
| EPS (Diluted) | -$0.08 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $665K | +90.0% | +664.4% |
| Current Assets | $1.1M | +19.1% | +47.5% |
| Total Assets | $9.1M | -2.7% | +32.2% |
| Current Liabilities | $6.7M | +3.7% | +109.6% |
| Total Liabilities | $8.8M | +17.9% | +172.1% |
| Stockholders' Equity | $297K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$913K | — | +49.3% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $779K | — | -42.3% |
| -91.9% |